While there is evidence to suggest that REP-1 regulates retinal capillary networks and choriocapillaris (CC) as well as post-translational protein modification and intracellular molecular trafficking in RPE (5–7), we do not yet understand how defects in REP-1 cause the CHM clinical features. Here, CHM is linked to choroideremia.